SNYSanofi

$45.44

$41.3152 weeks$49.59

Price

$45.44+1.1%1Y

1M+4.7%1Y+1.1%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

9/10

Value83

Quality84

Momentum39

Growth48

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

In the company’s own words · 20-F filed Feb 17, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$101.45B

1Y Return+1.1%

5Y Return+9.1%

Sanofi (SNY) reported revenue of €23.7B in H2 2025 (quarter ended December 31, 2025), up 35% from the same quarter a year earlier. That came with a gross margin of 77% and net income of €2.00B (8.4% of revenue). For the full year FY2025, revenue was €43.6B (+6.2% year on year) and net income €7.81B.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Drug Manufacturers - General

Ranks #9 of 16 by Smart Score